Topical applications in humans
Since modern civilisations overage and are increasingly confronted with lifestyle diseases or nosocomial infections, more and more people will develop open wounds that don’t heal.
Today about 110 million people suffer from pressure sores worldwide. The healing process is often hindered by bacterial infections caused by antibiotic resistant pathogens and therefore do not respond to conventional treatments.
The Lysando AG has developed a wound care spray for supporting of the healing process of chronic wounds which creates an optimum moist environment and a protective film. In addition, the spray can reduce the number of pathogenic bacteria. In first patient applications, the spray showed convincing results without side effects.
For 90% of the patients, the healing process started immediately after the first application of the wound spray and the wound size diminished.
Within 30 days, 40% of the wounds were healed completely.
A wound spray for long-term treatment
One of the first patients who was treated with the wound spray was a coma patient suffering from non-treatable MRSA-infected decubitus. As the risk of a bacterial sepsis raised dramatically and the condition of the patient worsened, the responsible physician decided to use the wound spray as a last option.
Healing process of wound started in the first two weeks. However, treatment was continued for additional two months. Finally, after 27 months, the wound healed completely.